Independent Financial Group’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$676K Buy
3,608
+940
+35% +$177K 0.01% 850
2026
Q1
$518K Buy
2,668
+254
+11% +$49K 0.01% 919
2025
Q4
$444K Sell
2,414
-30
-1% -$5.26K 0.01% 959
2025
Q3
$375K Buy
2,444
+118
+5% +$17.9K 0.01% 981
2025
Q2
$325K Sell
2,326
-214
-8% -$30K 0.01% 989
2025
Q1
$373K Buy
2,540
+124
+5% +$17.9K 0.01% 837
2024
Q4
$317K Buy
2,416
+28
+1% +$3.92K 0.01% 881
2024
Q3
$372K Sell
2,388
-88
-4% -$14.2K 0.01% 778
2024
Q2
$386K Buy
2,476
+51
+2% +$7.67K 0.02% 713
2024
Q1
$329K Buy
2,425
+88
+4% +$11.7K 0.02% 743
2023
Q4
$315K Hold
2,337
0.02% 701
2023
Q3
$316K Buy
2,337
+49
+2% +$6.69K 0.02% 637
2023
Q2
$328K Buy
2,288
+39
+2% +$5.74K 0.02% 607
2023
Q1
$312K Buy
2,249
+181
+9% +$24.4K 0.03% 590
2022
Q4
$280K Sell
2,068
-125
-6% -$15.7K 0.02% 577
2022
Q3
$240K Hold
2,193
0.02% 609
2022
Q2
$290K Sell
2,193
-250
-10% -$32.8K 0.03% 514
2022
Q1
$324K Hold
2,443
0.03% 570
2021
Q4
$285K Buy
2,443
+233
+11% +$27.4K 0.02% 618
2021
Q3
$265K Buy
+2,210
New +$257K 0.03% 566

Other funds holding AZN

Independent Financial Group's AZN Position: Q2 2026 in Review

Independent Financial Group increased its AstraZeneca (AZN) stake by 35% in Q2 2026, buying an estimated $177K and bringing the position to 3,608 shares worth $676K. The position accounts for 0.01% of the portfolio, ranked #850.

Independent Financial Group first reported a position in AZN in Q3 2021 and has held it in 20 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Independent Financial Group held 3,608 shares of AstraZeneca worth $676K as of Q2 2026.
  • Independent Financial Group bought 940 AstraZeneca shares in Q2 2026, an estimated $177K.
  • AstraZeneca made up 0.01% of Independent Financial Group's portfolio in Q2 2026, its #850 holding.
  • Independent Financial Group first reported a position in AstraZeneca in Q3 2021 and has held it in 20 quarters since.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Independent Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.